The number of patients receiving peritoneal dialysis has increased worldwide. Herein, we report the first case to our knowledge of continuous ambulatory peritoneal dialysis (CAPD) peritonitis caused by Micrococcus aloeverae, which was initially reported to be caused by Micrococcus luteus in the dialysate culture report but later identified by 16S ribosomal ribonucleic acid (rRNA) gene sequencing as M. aloeverae. A 59-year-old woman visited the emergency room due to abdominal pain. She was hospitalized with CAPD peritonitis. The patient initially responded to empirical antibiotic treatment comprising intraperitoneal cefazolin (15 mg/kg/day) and ceftazidime (1 g/day); however, the leukocyte count of dialysate effluent increased again. M. luteus was isolated four times from peritoneal dialysate cultures. We treated the patient with intraperitoneal administration of vancomycin (2 g loading, followed by 1 g every 7 days) but needed to switch from CAPD to temporary hemodialysis. We analyzed the 16S rRNA sequence to confirm the exact causative organism, and the results revealed that the organism was M.
Introduction
Micrococcus spp. are gram-positive, aerobic, nonendospore-forming cocci. The organisms can be found in many places such as human skin, water, dust, and soil.
Micrococcus is generally considered a harmless bacterium, but there have been rare cases of Micrococcus infection in people with compromised immune systems 1 . The case of continuous ambulatory peritoneal dialysis (CAPD) peritonitis herein was first attributed to Micrococcus luteus based on peritoneal dialysis cultures but later confirmed to be due to Micrococcus aloeverae using 16S ribosomal ribonucleic acid (rRNA) sequencing.
Case Report
A 59-year-old woman visited the emergency department on the fourth day. Furthermore, on the fourth day of hospitalization, we received the peritoneal fluid culture result from an aerobic incubation on a blood chocolate agar plate ( Fig. 1) selected antibiotics (erythromycin, penicillin, and vancomycin) was performed using the E-test method. The cultured strain showed resistance to erythromycin and susceptibility to vancomycin (Fig. 2) . However, after the third administration of vancomycin, the patient complained of abdominal pain again. We decided to remove the peritoneal catheter and switched her to hemodialysis via a permanent jugular catheter. After removal of the peritoneal dialysis catheter, she felt better, and the serum C-reactive protein level returned to within the normal range, therefore, we terminated the antibiotic therapy.
The removed CAPD catheter was incubated, but no bacterial growth was observed. We performed CAPD catheter re-insertion after a month and restarted peritoneal dialysis without any complication.
We analyzed the 16S rRNA sequence to confirm the causative organism. The genomic DNA was extracted from the cultured microorganisms, and polymerase chain reaction was performed with 16S rRNA. The 16S rRNA was amplified using universal primers (forward, 5'-AGT TTGATCCTGGCTCAG-3'; reverse, 5'-GTATTGCCGCGG CTGCTG-3') and sequenced. M. aloeverae strain AE-6 was verified with 605/607 (99.7%) similarity (GenBank acces-sion number: NR134088.1).
Discussion
Recently, the number of patients receiving peritoneal dialysis has increased worldwide 2 . Therefore, it is important to prevent and diagnose the complications of peritoneal dialysis. Peritonitis is a major complication of peritoneal dialysis and is associated with mortality in patients receiving peritoneal dialysis 3 . The typical spectrum of organisms causing peritonitis includes: gram-positive organisms (67%), gram-negative organisms (28%), fungi (2.5%), and anaerobic organisms (2.5%) 4 . 
